Feline sporotrichosis is a subcutaneous mycosis caused by the fungus Sporothrix schenckii. The disease can range from isolated cutaneous lesions to severe and disseminated forms, mainly affecting adult male cats that are not neutered. The clinical aspects of feline sporotrichosis are explored, including the presentation of cutaneous lesions, respiratory signs, and systemic manifestations such as lethargy, anorexia, and fever. Treatment is detailed, emphasizing the importance of accurate diagnosis and the need for prolonged treatment, which can last weeks to months. Therapeutic options include potassium iodide, azoles (such as itraconazole and ketoconazole), terbinafine, and amphotericin B, as well as non-pharmacological measures such as thermotherapy, cryosurgery and surgical excision. The paper also discusses the combination of potassium iodide and itraconazole as an effective therapeutic option, as well as addressing recommendations for managing drug toxicity, indications for euthanasia in severe cases, and general recommendations for disease management and prevention. Finally, the persistence of sporotrichosis as a neglected disease in Brazil is highlighted, with the treatment of cats representing a continuous and longterm challenge.